Go Back   AFA Forums > Science, Logic and Reason > General Science News

General Science News Got an idea, article or video you want to share on Science, Philosophy or Evolution?

Reply
 
Thread Tools
  #1  
Old 31st May 2012, 03:05 PM
Darwinsbulldog's Avatar
Darwinsbulldog Darwinsbulldog is online now
Science Moderator
 
Join Date: Jan 2009
Location: Perth
Posts: 11,458
Default 21st Century Bloodletting Reduces Cardiovascular Risk

Quote:
21st Century Bloodletting Reduces Cardiovascular Risk

ScienceDaily (May 29, 2012) — It seems that while the practice of bloodletting throughout history had little or no effect on most diseases, and the practice was abandoned in the 19th century, new research published in BioMed Central's open access journal BMC Medicine demonstrates that blood donation has real benefits for obese people with metabolic syndrome. Two sessions of bloodletting were enough to improve blood pressure and markers of cardiovascular disease.
Metabolic syndrome is the name given to a host of difficulties affecting people who are obese. This includes insulin resistance, glucose intolerance, dyslipidemia and hypertension and leads to an increased risk of diabetes and cardiovascular disease. Since it is known that accumulation of iron in the body is also associated with hypertension and diabetes researchers from Berlin and University Duisburg-Essen randomly assigned patients with metabolic syndrome into two groups, those undergoing iron reduction by phlebotomy and controls.
The iron-reduction patients had 300ml of blood removed at the start of the trial and between 250 and 500ml removed four weeks later. Six weeks later, allowing plenty of time for blood volume to be replaced, the patients who gave blood had a significant reduction in systolic blood pressure (from 148 mmHg to 130 mmHg) as well as reduction in blood glucose levels and heart rate, and an improvement in cholesterol levels (LDL/HDL ratio).
Prof Andreas Michalsen from the Charité-University Medical Centre, Berlin, who led this research explained, "Consecutive reduction in iron stores was able to improve markers of cardiovascular risk and glycemic control. Consequently blood donation may prevent not just diabetes but also cardiovascular disease for the obese. Obviously this treatment will not be suitable for people with anemia however for those eligible for treatment blood donation may prevent escalation of their condition."
http://www.sciencedaily.com/releases...0529211645.htm

FULL PAPER:-

Houschyar, K., R. Ludtke, et al. (2012). "Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: Results from a randomized clinical trial." BMC Medicine 10(1): 54.
Quote:
BACKGROUND:Metabolic syndrome (METS) is an increasingly prevalent but poorly understood clinical entity characterized by insulin resistance, glucose intolerance, dyslipidemia, hypertension and obesity. Increased oxidative stress catalyzed by accumulation of iron in excess of physiologic requirements has been implicated in the pathogenesis of METS but cause-and-effect relationships remain uncertain. The hypothesis that phlebotomy-induced reduction of body iron stores would alter clinical manifestations of METS was tested by a randomized trial.METHODS:In a randomized-controlled single-blinded clinical trial 64 patients with METS were randomly assigned to iron reduction by phlebotomy (n=33) or to a waiting-list control group (n=31). Iron reduction patients had 300ml of blood removed at entry and between 250-500ml removed after 4 weeks depending on entry ferritin levels. Primary outcomes were change of systolic blood pressure and of insulin sensitivity as measured by HOMA-Index after 6 weeks. Secondary outcomes included HbA1c, plasma-glucose, blood lipids and heart rate.RESULTS:Systolic blood pressure decreased from 148.5+/-12.3 mmHg to 130.5+/-11.8 mm Hg in the phlebotomy group and from 144.7+/-14.4 mmHg to 143.8+/-11.9 mmHg in the control group (difference -16.6 mmHg;95%-CI:-20.7;-12.5;p<0.001). No significant effect on the HOMA-Index was observed. Among secondary outcomes, blood glucose, HbA1c, LDL/HDL ratio and heart rate were significantly decreased by phlebotomy. Changes in blood pressure and HOMA-Index were correlated with reduction of ferritin.CONCLUSIONS:In patients with METS, phlebotomy with consecutive reduction of body iron stores lowered blood pressure and resulted in improvements of markers of cardiovascular risk and glycemic control. Blood donation may have beneficial effects for donating subjects with METS. Trial registration: ClinicalTrials.gov: NCT01328210 Please see related article:
http://www.biomedcentral.com/1741-7015/10/53
__________________
The religious are not necessarily insane, but oft look to it as a state of considerable virtue.
Reply With Quote
Reply

Bookmarks

Thread Tools

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT +10. The time now is 05:29 PM.


Powered by vBulletin® Version 3.8.8
Copyright ©2000 - 2014, vBulletin Solutions, Inc.